N Yuki Selected Research

Guillain-Barre Syndrome

10/2011	Neuromuscular transmission is not impaired in axonal Guillain--Barré syndrome.
11/2005	Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
3/2005	Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
1/2005	Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome.
8/2004	Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
6/2004	Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration.
3/2004	Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry.
3/2004	Acute facial diplegia and hyperreflexia: A Guillain-Barré syndrome variant.
5/2003	Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome.
10/2002	Asymmetric pharyngeal-cervical-brachial weakness associated with anti-GT1a IgG antibody.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Yuki Research Topics

Disease

30	Guillain-Barre Syndrome 10/2011 - 02/2000
14	Miller Fisher Syndrome (Fisher Syndrome) 02/2016 - 04/2000
13	Infections 01/2011 - 03/2000
11	Ophthalmoplegia (External Ophthalmoplegia) 02/2016 - 05/2000
8	Ataxia (Dyssynergia) 02/2016 - 05/2000
4	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2017 - 06/2000
4	Polyneuropathies (Polyneuropathy) 01/2017 - 06/2000
4	Encephalitis (Encephalitis, Rasmussen) 05/2008 - 03/2001
4	Enteritis 11/2001 - 04/2000
3	Progressive Bulbar Palsy (Fazio Londe Syndrome) 02/2016 - 05/2001
3	Chronic Hepatitis C 02/2010 - 12/2000
3	Diarrhea 02/2006 - 08/2000
2	Paralysis (Palsy) 11/2006 - 07/2003
2	Demyelinating Diseases (Demyelinating Disease) 03/2005 - 10/2002
2	Facial Paralysis (Facial Palsy) 06/2002 - 06/2001
1	Disorders of Excessive Somnolence (Hypersomnia) 02/2016
1	Suppuration 10/2015
1	Pressure Ulcer (Bedsore) 10/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2014
1	Muscle Weakness 01/2011
1	Measles 12/2009
1	Common Variable Immunodeficiency 12/2009
1	Thrombocytopenia (Thrombopenia) 12/2009
1	Multiple Sclerosis 12/2009
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2009
1	Speech Disorders (Cluttering) 02/2006
1	Neurologic Manifestations (Neurological Manifestations) 11/2005
1	Headache (Headaches) 01/2005
1	Mycoplasma Pneumonia 03/2004
1	Mycoplasma Infections 03/2004
1	Gastroenteritis 05/2003
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2003
1	Critical Illness (Critically Ill) 12/2002
1	Disease Progression 10/2002
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 09/2002
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 06/2002
1	Viremia 12/2001
1	Chronic Hepatitis B 12/2001
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 11/2001
1	Short Bowel Syndrome 09/2001
1	Intestinal Failure 09/2001
1	Herpes Simplex 07/2001
1	Pain (Aches) 06/2001
1	Pharyngitis (Sore Throat) 05/2001
1	Cough 05/2001
1	Brain Stem Infarctions (Weber Syndrome) 02/2001
1	Hypersensitivity (Allergy) 02/2001
1	Melanoma (Melanoma, Malignant) 02/2001
1	Neuritis (Polyneuritis) 01/2001
1	Paresthesia (Dysesthesia) 01/2001

Drug/Important Bio-Agent (IBA)

27	Immunoglobulin G (IgG)IBA 01/2017 - 04/2000
18	AntibodiesIBA 01/2017 - 02/2000
14	GangliosidesIBA 02/2006 - 03/2000
7	Immunoglobulin M (IgM)IBA 01/2011 - 06/2000
5	AutoantibodiesIBA 01/2017 - 05/2005
5	Intravenous Immunoglobulins (IVIG)FDA Link 12/2009 - 01/2001
5	EpitopesIBA 11/2006 - 04/2000
5	Amantadine (Aman)FDA LinkGeneric 03/2005 - 10/2000
4	ganglioside M1b (GM1b)IBA 08/2006 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2000
2	Immunoglobulins (Immunoglobulin)IBA 12/2009 - 04/2001
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2005 - 05/2001
2	SteroidsIBA 01/2005 - 06/2001
2	LipopolysaccharidesIBA 08/2001 - 08/2000
2	InterferonsIBA 07/2001 - 12/2000
2	G(M1) GangliosideIBA 06/2001 - 04/2000
2	sulfate-3-glucuronyl paraglobosideIBA 05/2001 - 06/2000
2	Myelin-Associated GlycoproteinIBA 05/2001 - 06/2000
1	Arginine (L-Arginine)FDA Link 10/2015
1	Glutamine (L-Glutamine)FDA Link 10/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2011
1	AcidsIBA 01/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	Fosfomycin FDA Link 01/2011
1	Explosive Agents (Explosives)IBA 01/2011
1	Ribavirin (Virazole)FDA LinkGeneric 02/2010
1	Toll-Like Receptor 3IBA 02/2010
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2009
1	PrionsIBA 12/2009
1	IV(4)-galactosyl-N-acetylganglioside GD1aIBA 08/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2005
1	Prednisolone (Predate)FDA LinkGeneric 08/2005
1	OligosaccharidesIBA 05/2005
1	Methylprednisolone FDA LinkGeneric 01/2005
1	galactocerebrosideIBA 03/2004
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2003
1	PrebioticsIBA 12/2002
1	Hepatitis B Core AntigensIBA 12/2001
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2001
1	Indicators and Reagents (Reagents)IBA 05/2001
1	Neuraminidase (Sialidase)IBA 02/2001

Therapy/Procedure

9	Therapeutics 08/2005 - 04/2000
3	Plasma Exchange 08/2005 - 10/2000
3	Plasmapheresis 02/2001 - 10/2000
2	Immunotherapy 01/2007 - 04/2001
1	Artificial Respiration (Mechanical Ventilation) 09/2014
1	Oral Administration 01/2011
1	Immunomodulation 01/2007
1	Retreatment 12/2000